| Application no. and date | 08725055.1 (espacenet) (Federated) (European Patent Register), 20080201 | | Patent/reg. no. and date | DK/EP 2120999, 20120829 | | Publication date | 20091125 | | Priority no. and date | US 900580 P, 20070209, US 932762 P, 20070531, US 937365 P, 20070626, US 528, 20071025, US 52807 P, 20071025 | | EP pub. no. and date |
EP 2120999 20091125 | | Effective date | | | Applicant/owner | Acceleron Pharma, Inc., 128 Sidney Street
Cambridge, MA 02139, US | | Applicant ref. no. | P19718DKEP | | Inventor | KUMAR, Ravindra, 421 Arlington Street
Acton, MA 01720, US,
KNOPF, John, 147 Robbins Drive
Carlisle, MA 01741, US,
SEEHRA, Jasbir, 3 Lincoln Terrace
Lexington, MA 02421-6818, US | | Representative | Patrade A/S, Ceresbyen 75, 8000 Århus C | | Opponent | | | IPC Class | A61K 38/18 (2006.01) , A61P 35/00 (2006.01) | | Title | Farmaceutiske sammensætninger omfattende Activin-ActRIIA antagonister samt anvendelse deraf ved forebyggelse eller behandling af multipelt myelom | | Int. application no. | US2008001354 | | Int. publication no. | WO2008100384 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
